Cargando…
Normobaric oxygen may correct chronic cerebral ischemia‐mediated EEG anomalies
AIMS: To explore the safety and efficacy of normobaric oxygen (NBO) on correcting chronic cerebral ischemia (CCI) and related EEG anomalies. METHODS: This prospective randomized trial (NCT03745092) enrolled 50 cases of CCI patients, which were divided into NBO (8 L/min of oxygen supplement) group an...
Autores principales: | Ding, Jia‐Yue, Liu, Yu, Rajah, Gary‐B., Chen, Zhi‐Ying, Zhang, Shi‐Yong, Ding, Yu‐Chuan, Ji, Xun‐Ming, Meng, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446210/ https://www.ncbi.nlm.nih.gov/pubmed/34242498 http://dx.doi.org/10.1111/cns.13703 |
Ejemplares similares
-
Normobaric Oxygen May Ameliorate Cerebral Venous Outflow Disturbance-Related Neurological Symptoms
por: Ding, Jiayue, et al.
Publicado: (2020) -
Normobaric Oxygen (NBO) Therapy Reduces Cerebral Ischemia/Reperfusion Injury through Inhibition of Early Autophagy
por: Wang, Meng, et al.
Publicado: (2021) -
Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
por: Ding, Jiayue, et al.
Publicado: (2019) -
Normobaric oxygen may attenuate the headache in patients with patent foramen povale and migraine
por: Wang, Mengqi, et al.
Publicado: (2023) -
Normobaric oxygen for cerebral ischemic injury
por: Chen, Chunhua, et al.
Publicado: (2013)